KISS1 and cancer: According to various clinical data, a decrease in KiSS-1 and/or GPR54 expression has been shown to be associated with poorer prognosis in cancer patients and, therefore, the expression of KiSS-1 and/or GPR54 might be useful predictive biomarkers in medical outcomes.